Brief: Alteogen receives patent
Oct 13 (Reuters) - Alteogen Inc 196170.KQ :
* Says it receives patent named modified antibody in which
motif comprising cysteine residue is bound, modified
antibody-drug conjugate comprising the modified antibody, and
production
Source text in Korean: https://goo.gl/PpQwrz
Further company coverage: 196170.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; Reuters Messaging:
Yinglan.Ma@thomsonreuters.com@reuters.net))
Recent news on Alteogen
See all newsDeals of the day-Mergers and acquisitions
Novartis signs deal worth up to $3.2 billion for Alteogen's drug delivery technology
Brief: Alteogen To Invest 253 Billion Won In Construction Of New Factory
Brief: Alteogen Q2 Operating. Profit 34.2 Billion Won
Brief: Alteogen - Signs Exclusive License Agreement For Alt-B4 Recombinant Human Hyaluronidase